Lancet Diabetes Endocrinology
1 2 "Synthesis of Cyanocobalamin by Robert B
How to Avoid GLP-1 Side Effects if You Have Type 2 Diabetes GLP-1 receptor agonists, such as semaglutide, and dual agonists, like tirzepatide, have become powerful tools for managing type 2 diabetes
The five least at-risk states: Massachusetts Awareness Gap Index: 18.9 (11% GLP-1 usage and 92 searches per 100,000 residents) Rhode Island Awareness Gap Index: 20.7 (7,5% GLP-1 usage and 82 searches per 100,000 residents) Nevada Awareness Gap Index: 20.6 (8% GLP-1 usage and 83.4 searches per 100,000 residents) Virginia Awareness Gap Index: 26,5 (12% GLP-1 usage and 90 searches per 100,000 residents) New York Awareness Gap Index: 25.5 (14% GLP-1 usage and 89 searches per 100,000 residents) The gap between top and bottom is stark: West Virginias awareness gap ratio is nearly five times worse than Hawaiis
Severe diabetic retinopathy with macular edema may worsen with rapid glucose lowering in type 2 diabetes
Ros Body Program bundles most of the essentials into its membership, with medications billed separately